Header
Sir Ganga Ram Hospital, New Delhi
Liver Cancer Stages, Survival Rates and Treatment.
Medically Reviewed by Dr. Aditya Sarin, MD, DrNB
Gastrointestinal Cancer · Sir Ganga Ram Hospital, New Delhi

Liver Cancer —
Understand. Diagnose. Treat.

Liver cancer begins in the liver — a vital organ responsible for detoxification, digestion, and metabolism. Expert care by Dr. Aditya Sarin, ESMO Board Certified Medical Oncologist.

Medical Disclaimer

This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of liver cancer is different. Please consult Dr. Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.

Key Types Hepatocellular Carcinoma Cholangiocarcinoma Hepatoblastoma HCC Bile Duct Cancer

Early detection saves lives. Liver cancer often shows no symptoms in early stages — if you have risk factors like hepatitis or cirrhosis, schedule a screening with Dr. Aditya Sarin today.

Section 01

What is Liver Cancer?

Liver cancer is a type of cancer that begins in the liver — an essential organ responsible for detoxification, digestion, and metabolism. The most common type is hepatocellular carcinoma (HCC), which originates from the liver's main cells, called hepatocytes. Other types include intrahepatic cholangiocarcinoma (bile duct cancer) and hepatoblastoma, a rare childhood liver cancer.

If not detected early, liver cancer can spread to other parts of the body, making treatment significantly more challenging. Individuals with chronic liver conditions such as hepatitis B/C or cirrhosis are at considerably elevated risk and benefit most from regular surveillance.

Section 02

Types of Liver Cancer

Liver cancer is classified based on the cells where it originates:

Most Common

Hepatocellular Carcinoma (HCC)

The most prevalent form, originating in hepatocytes — the main liver cells. Often associated with cirrhosis or chronic hepatitis B/C infection.

Bile Duct

Intrahepatic Cholangiocarcinoma

Arises in the bile ducts within the liver. Accounts for about 10–15% of liver cancers and is often diagnosed at a more advanced stage.

Childhood

Hepatoblastoma

A rare liver cancer occurring predominantly in children under 3 years of age. Generally responds well to treatment when caught early.

Rare · Aggressive

Angiosarcoma / Hemangiosarcoma

A very rare and aggressive cancer arising from blood vessels in the liver. Requires prompt, specialized oncological management.

Section 03

Symptoms of Liver Cancer

Liver cancer may produce no noticeable symptoms in its early stages. As the disease progresses, common signs include:

Unexplained weight loss
Loss of appetite
Persistent abdominal pain or swelling
Jaundice — yellowing of skin and eyes
Nausea and vomiting
Fatigue and general weakness
White or chalky stools
A lump or mass in the upper right abdomen

Note: Liver cancer is often asymptomatic in early stages. If you have known risk factors such as chronic hepatitis, cirrhosis, or fatty liver disease, do not wait for symptoms — seek periodic screening immediately.

Section 04

Causes & Risk Factors

Several factors can significantly increase the risk of developing liver cancer:

Chronic Hepatitis B or C

These viral infections cause long-term liver damage and are leading drivers of liver cancer risk.

Cirrhosis

Scarring of the liver from alcohol use, hepatitis, or other causes significantly elevates cancer risk.

Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) can cause progressive liver damage linked to cancer.

Excessive Alcohol

Long-term alcohol abuse leads to cirrhosis, a strong precursor to liver cancer.

Aflatoxin Exposure

Harmful mold toxins found in contaminated food are a known carcinogen for liver cancer.

Diabetes & Obesity

These metabolic conditions are associated with fatty liver disease, a liver cancer risk factor.

Genetic Disorders

Conditions like hemochromatosis (excess iron storage in the liver) increase cancer susceptibility.

Section 05

Stages of Liver Cancer

Understanding the stage of liver cancer is essential for determining the most appropriate treatment approach and assessing prognosis.

IStage

Localized — Single Tumor, No Spread

Cancer is confined to the liver with a single tumor and has not spread to blood vessels, lymph nodes, or other organs. Best outcomes with surgery or ablation.

IIStage

Vascular Involvement or Multiple Small Tumors

Cancer has grown into nearby blood vessels, or multiple small tumors are present within the liver but haven't spread beyond it. Surgical options may still apply.

IIIStage

Large Tumors or Regional Lymph Node Spread

Larger tumors present, or cancer has spread to major blood vessels or regional lymph nodes. Treatment typically involves targeted therapy, TACE, or TARE.

IVStage

Distant Metastasis

Cancer has spread to distant organs such as the lungs or bones. Management focuses on systemic therapies including immunotherapy and targeted treatment, as well as palliative care.

Section 06

Survival Rates by Stage

Survival statistics are population averages. They describe outcomes across large groups of patients and do not predict what will happen to any individual patient. Liver cancer has one of the lowest overall survival rates among common cancers, largely because it is frequently linked to underlying liver disease that limits treatment options.

Liver cancer survival rate in the United States

Stage at diagnosis
5-year rate
Localized — confined to the liver
37.4%
Regional — spread to nearby structures or lymph nodes
12.1%
Distant — spread to other organs
3.3%

Source: American Cancer Society, Liver Cancer Survival Rates, based on SEER data for cases diagnosed between 2014 and 2020.

Liver cancer survival rate in Asia

Nationally representative, stage-wise survival data specific to liver cancer is limited in India. The closest available regional context comes from a systematic review of Asian countries, which found considerably lower overall survival compared with Western data — consistent with the global pattern that liver cancer diagnosed against a background of chronic hepatitis or cirrhosis tends to carry a worse prognosis.

Source: The survival rate of hepatocellular carcinoma in Asian countries, a systematic review and meta-analysis, EXCLI Journal.

Section 07

Diagnosis of Liver Cancer

Accurate and timely diagnosis is critical. Doctors use a combination of the following tests to detect and confirm liver cancer:

Blood Tests
  • Alpha-fetoprotein (AFP) tumour marker
  • Liver function tests
  • Hepatitis B/C serology
Imaging Tests
  • Ultrasound — first-line screening
  • CT Scan / MRI — size and extent
  • PET Scan — distant metastasis
Liver Biopsy
  • Tissue sample of suspicious area
  • Confirmed malignancy by pathology
  • Guides treatment decisions
Function Tests
  • Assess overall liver health
  • Guide surgical candidacy
  • Child-Pugh / MELD scoring
Section 08

Treatment Options for Liver Cancer

Treatment depends on the stage of cancer, liver function, and overall health. A multidisciplinary approach ensures the best possible outcome for each patient.

Surgery

The primary curative option for eligible patients with localized liver cancer.

  • Liver Resection (partial hepatectomy)
  • Liver Transplantation for advanced cases

Ablative Therapies

For patients unable to undergo surgery — targeted destruction of tumour tissue.

  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Cryoablation (freezing cancer cells)

Transarterial Therapies

Advanced interventional treatments for unresectable liver cancer.

  • TACE — chemo delivered directly to tumour
  • TARE — radioactive beads target tumours

Targeted Therapy

Drugs targeting specific molecular pathways driving cancer cell growth — with fewer side effects than traditional chemotherapy.

Immunotherapy

Checkpoint inhibitors and other agents that help the immune system recognize and destroy liver cancer cells — especially in advanced disease.

Chemotherapy

Drug treatment to kill cancer cells — often used in combination with other therapies. Generally less effective as a standalone for liver cancer but beneficial in select regimens.

Radiation Therapy

External beam radiation or SBRT (Stereotactic Body Radiation Therapy) used in select cases where other local treatments are not feasible.

Palliative Care

Focuses on comfort, pain management, and improving quality of life — available alongside curative treatments at any stage.

Section 09

Latest Advances in Liver Cancer Treatment

Systemic and combination therapy for advanced liver cancer has seen meaningful data updates over the past year, though a major recent adjuvant trial also produced a disappointing result worth noting honestly. As of 2026, notable developments include the following.

1
ASCO GI 2026 · Intermediate-Stage HCC

Combination therapy outperforming standard local treatment

Data presented at ASCO GI 2026 showed that atezolizumab combined with bevacizumab led to a longer time to treatment failure than transarterial chemoembolization (TACE) alone in patients with intermediate-stage hepatocellular carcinoma — supporting a shift toward systemic therapy even before disease becomes fully advanced.

Source: Oncology News Central — Liver Cancer, Expert Oncology Information, 2026.

2
Adjuvant Pembrolizumab · Setback

A setback for adjuvant immunotherapy

Adjuvant pembrolizumab, given after surgery to try to prevent recurrence, failed to improve recurrence-free survival in hepatocellular carcinoma patients — underscoring that preventing recurrence after surgery remains a significant unmet need in this cancer.

Source: Oncology News Central — Liver Cancer, Expert Oncology Information, 2026.

Whether either finding changes a specific patient's treatment plan depends on tumour stage, liver function, and prior treatment, and should be discussed directly with an oncologist.
Section 10

Life After Liver Cancer Treatment

Regular Monitoring

Frequent follow-up tests including AFP levels and imaging ensure cancer does not return.

Diet & Lifestyle Changes

A liver-healthy diet, alcohol avoidance, and maintaining a healthy weight improve outcomes and liver function.

Emotional & Psychological Support

Counseling and support groups help patients and families cope with the emotional impact of liver cancer treatment.

Hepatitis Management

Antiviral treatment for underlying hepatitis B/C to prevent recurrence and further liver damage.

Post-Transplant Care

Lifelong immunosuppressive therapy and regular check-ups for patients who receive a liver transplant.

Section 11

Frequently Asked Questions about Liver Cancer

Why does liver cancer have a lower survival rate than many other cancers?

Liver cancer is often diagnosed in people who already have chronic liver disease, such as hepatitis or cirrhosis, which limits which treatments, including surgery, are safe to use. It also frequently produces no symptoms until it is more advanced, so many cases are diagnosed at a later stage.

Do I need regular screening if I have hepatitis B or C?

Yes. People with chronic hepatitis B or C, or cirrhosis from any cause, are considered high risk and generally benefit from periodic ultrasound and blood marker screening, since this allows liver cancer to be caught while still localized and more treatable.

Is a liver transplant a treatment option for liver cancer?

For select patients with liver cancer confined to the liver, particularly those with underlying cirrhosis that would make resection risky, a liver transplant can be both curative for the cancer and treat the underlying liver disease. Eligibility depends on tumour size, number, and overall health.

What is the difference between TACE and TARE?

Both are transarterial therapies delivered directly into the blood vessels feeding a liver tumour. TACE delivers chemotherapy combined with an agent that blocks blood flow to the tumour, while TARE delivers radioactive beads directly to the tumour. The choice between them depends on tumour characteristics and liver function.

Can fatty liver disease turn into liver cancer?

Non-alcoholic fatty liver disease can progress to more severe liver damage over time and is an increasingly recognised risk factor for liver cancer, even in the absence of significant alcohol use or viral hepatitis, which is why lifestyle management matters for liver health more broadly.

Is chemotherapy effective for liver cancer?

Traditional chemotherapy is generally less effective for liver cancer than for many other cancer types when used alone, and is more often used in combination with other therapies or in specific situations, since targeted therapy, immunotherapy, and localized treatments tend to play a larger role.

What is the best treatment approach for Liver Cancer in Delhi?

Effective liver cancer treatment in Delhi depends on close coordination between oncology and liver function assessment, since underlying conditions like hepatitis or cirrhosis directly affect which treatments, including surgery, are safe to use. Dr. Aditya Sarin offers this coordinated approach, including transarterial and targeted therapy options, for liver cancer patients at Sir Ganga Ram Hospital, New Delhi.
Section 12 · Why Dr. Aditya Sarin

Why Trust Dr. Aditya Sarin for Liver Cancer Care?

Early detection dramatically improves survival — schedule a screening at Sir Ganga Ram Hospital today.

Expert Liver Cancer Specialists

Experienced oncologists with advanced training in gastrointestinal and hepatic cancers, backed by international certification.

Comprehensive Diagnostic Facilities

State-of-the-art imaging including PET-CT, MRI, ultrasound, and advanced laboratory AFP testing for accurate staging.

Full Spectrum of Treatments

Surgery, ablation, TACE, TARE, targeted therapy, immunotherapy — all coordinated under a single expert clinical team.

Personalised Treatment Plans

Every plan is tailored to the patient's cancer stage, liver function, comorbidities, and overall health profile.

Holistic Care & Support

Post-treatment recovery, diet counseling, emotional well-being services, and ongoing monitoring for complete patient care.

Mon – Fri (Morning) 10:00 AM – 12:00 PM
Mon – Fri (Evening) 4:00 PM – 6:00 PM
Saturday - Sunday Closed

Don't Wait — Early Diagnosis Saves Lives

If you have risk factors or are experiencing symptoms, schedule a consultation with Dr. Aditya Sarin today. Expert care, personalised for you.

📅 Book Your Appointment

Liver Cancer